NLRP3 and ischemic stroke: Therefore, the current study aimed to examine the hypothesis of whether EA attenuates cerebral I/R injury through α7nAChR-mediated inhibition of NLRP3 inflammasome caused inflammatory response to provide a novel therapeutic target for ischemic stroke and a remarkable theoretical basis for the neuroprotection of EA.